{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:45:12Z","timestamp":1762497912669,"version":"build-2065373602"},"reference-count":120,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Migraine is one of the most painful and debilitating conditions, which is characterized\nby a pulsating headache. Many therapeutic strategies are being used to prevent and treat the symptoms\nand underlying pathology. A relatively high number of different medications are currently being\nused for migraine prevention in clinical practice. However, these compounds were initially developed\nfor other indications and were different in their mechanisms of action. This review mainly\nsummarized all the conventional and phytocompounds currently present for the treatment of migraine.\nFurther, we also discussed therapeutic potential and clinical studies of natural compounds\nfor the treatment of migraine prophylaxis under various chemical categories like flavonoids, polyphenols,\nalkaloids, glycosides, terpenoids, and lactone, acid, and alcohol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715249308649240730093046","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:17:19Z","timestamp":1727137039000},"page":"322-336","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Phytocompounds for Effective Management of Migraine: Current and Future Prospectives"],"prefix":"10.2174","volume":"25","author":[{"given":"Swapnil","family":"Randive","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-1976","authenticated-orcid":true,"given":"Sanjeev Kumar","family":"Sahu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Vyas","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/cells11172767","volume":"11","author":"Villar-Martinez M.D.","year":"2022","unstructured":"Villar-Martinez M.D.; Goadsby P.J.; Pathophysiology and therapy of associated features of migraine. Cells  2022,11(17),2767","journal-title":"Cells"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.14024","volume":"61","author":"Burch R.","year":"2021","unstructured":"Burch R.; Rizzoli P.; Loder E.; The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache  2021,61(1),60-68","journal-title":"Headache"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"111557","DOI":"10.1016\/j.biopha.2021.111557","volume":"139","author":"Khan J.","year":"2021","unstructured":"Khan J.; Asoom L.I.A.; Sunni A.A.; Rafique N.; Latif R.; Saif S.A.; Almandil N.B.; Almohazey D.; AbdulAzeez S.; Borgio J.F.; Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother  2021,139,111557","journal-title":"Biomed Pharmacother"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0271678X17733655","volume":"39","author":"Hoffmann J.","year":"2019","unstructured":"Hoffmann J.; Baca S.M.; Akerman S.; Neurovascular mechanisms of migraine and cluster headache. J Cereb Blood Flow Metab  2019,39(4),573-594","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s10194-021-01353-0","volume":"22","author":"Erdener \u015e.E.","year":"2021","unstructured":"Erdener \u015e.E.; Kaya Z.; Dalkara T.; Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. J Headache Pain  2021,22(1),138","journal-title":"J Headache Pain"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11910-020-01037-3","volume":"20","author":"Lai J.","year":"2020","unstructured":"Lai J.; Dilli E.; Migraine aura: Updates in pathophysiology and management. Curr Neurol Neurosci Rep  2020,20(6),17","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1586\/14737175.2013.835587","volume":"13","author":"Niazi A.K.","year":"2013","unstructured":"Niazi A.K.; Andelova M.; Sprenger T.; Is the migrainous brain normal outside of acute attacks? Lessons learned from psychophysical, neurochemical and functional neuroimaging studies. Expert Rev Neurother  2013,13(9),1061-1067","journal-title":"Expert Rev Neurother"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","volume":"22","author":"Silberstein S.D.","year":"2002","unstructured":"Silberstein S.D.; Goadsby P.J.; Migraine: Preventive Treatment. Cephalalgia  2002,22(7),491-512","journal-title":"Cephalalgia"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.17712\/nsj.2016.3.20150506","volume":"21","author":"Al-Quliti K.W.","year":"2016","unstructured":"Al-Quliti K.W.; Assaedi E.S.; New advances in prevention of migraine. Neurosciences  2016,21(3),207-214","journal-title":"Neurosciences"},{"year":"2016","key":"ref=10","unstructured":"The International Classification of Headache Disorders 3rd edition (Beta version). Society, H.C.S.o.t.I.H. Available From:     https:\/\/www. ichd-3. org\/[Diakses 21 Desember 2017]2016"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Arnold M.","year":"2018","unstructured":"Arnold M.; Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia  2018,38(1),1-211","journal-title":"Cephalalgia"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/brain\/awt320","volume":"137","author":"Maniyar F.H.","year":"2014","unstructured":"Maniyar F.H.; Sprenger T.; Monteith T.; Schankin C.; Goadsby P.J.; Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain  2014,137(1),232-241","journal-title":"Brain"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"Dodick D.W.","year":"2018","unstructured":"Dodick D.W.; A phase-by-phase review of migraine pathophysiology. Headache  2018,58(S1)(Suppl. 1),4-16","journal-title":"Headache"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e95508","DOI":"10.1371\/journal.pone.0095508","volume":"9","author":"Moulton E.A.","year":"2014","unstructured":"Moulton E.A.; Becerra L.; Johnson A.; Burstein R.; Borsook D.; Altered hypothalamic functional connectivity with autonomic circuits and the locus coeruleus in migraine. PLoS One  2014,9(4),e95508","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cne.20688","volume":"493","author":"Burstein R.","year":"2005","unstructured":"Burstein R.; Jakubowski M.; Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol  2005,493(1),9-14","journal-title":"J Comp Neurol"},{"key":"ref=16","author":"Toimil B.","year":"2021","unstructured":"Toimil B.; Yoon H.; Li C.; Kohan L.;  Migraine  2021","journal-title":"Migraine"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2019.12.014","volume":"107","author":"Qubty W.","year":"2020","unstructured":"Qubty W.; Patniyot I.; Migraine pathophysiology. Pediatr Neurol  2020,107,1-6","journal-title":"Pediatr Neurol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/01.NAJ.0000805640.82646.ac","volume":"122","author":"Goetz A.","year":"2022","unstructured":"Goetz A.; McCormick S.; Phillips R.; Friedman D.; CE: Diagnosing and managing migraine. Am J Nurs  2022,122(1),32-43","journal-title":"Am J Nurs"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1526-4610.2011.01892.x","volume":"51","author":"Tfelt-Hansen P.C.","year":"2011","unstructured":"Tfelt-Hansen P.C.; Koehler P.J.; One hundred years of migraine research: Major clinical and scientific observations from 1910 to 2010. Headache  2011,51(5),752-778","journal-title":"Headache"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fnins.2019.00373","volume":"13","author":"Dreier J.P.","year":"2019","unstructured":"Dreier J.P.; Major S.; Lemale C.L.; Kola V.; Reiffurth C.; Schoknecht K.; Hecht N.; Hartings J.A.; Woitzik J.; Correlates of spreading depolarization, spreading depression, and negative ultraslow potential in epidural versus subdural electrocorticography. Front Neurosci  2019,13,373","journal-title":"Front Neurosci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/brain\/awz405","volume":"143","author":"Burke M.J.","year":"2020","unstructured":"Burke M.J.; Joutsa J.; Cohen A.L.; Soussand L.; Cooke D.; Burstein R.; Fox M.D.; Mapping migraine to a common brain network. Brain  2020,143(2),541-553","journal-title":"Brain"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00429-012-0437-y","volume":"218","author":"Maleki N.","year":"2013","unstructured":"Maleki N.; Becerra L.; Brawn J.; McEwen B.; Burstein R.; Borsook D.; Common hippocampal structural and functional changes in migraine. Brain Struct Funct  2013,218(4),903-912","journal-title":"Brain Struct Funct"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"Goadsby P.J.","year":"2017","unstructured":"Goadsby P.J.; Holland P.R.; Martins-Oliveira M.; Hoffmann J.; Schankin C.; Akerman S.; Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev  2017,97(2),553-622","journal-title":"Physiol Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.pharmthera.2012.08.011","volume":"136","author":"Edvinsson L.","year":"2012","unstructured":"Edvinsson L.; Villal\u00f3n C.M.; MaassenVanDenBrink A.; Basic mechanisms of migraine and its acute treatment. Pharmacol Ther  2012,136(3),319-333","journal-title":"Pharmacol Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","volume":"55","author":"Russo A.F.","year":"2015","unstructured":"Russo A.F.; Calcitonin gene-related peptide (CGRP): A new target for migraine. Annu Rev Pharmacol Toxicol  2015,55(1),533-552","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1098-3597(99)90037-6","volume":"1","author":"Cady R.K.","year":"1999","unstructured":"Cady R.K.; Diagnosis and treatment of migraine. Clin Cornerstone  1999,1(6),21-32","journal-title":"Clin Cornerstone"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainres.2011.01.002","volume":"1381","author":"Jaggi A.S.","year":"2011","unstructured":"Jaggi A.S.; Singh N.; Role of different brain areas in peripheral nerve injury-induced neuropathic pain. Brain Res  2011,1381,187-201","journal-title":"Brain Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"Iyengar S.","year":"2019","unstructured":"Iyengar S.; Johnson K.W.; Ossipov M.H.; Aurora S.K.; CGRP and the trigeminal system in migraine. Headache  2019,59(5),659-681","journal-title":"Headache"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/head.12081","volume":"53","author":"Schwedt T.J.","year":"2013","unstructured":"Schwedt T.J.; Schlaggar B.L.; Mar S.; Nolan T.; Coalson R.S.; Nardos B.; Benzinger T.; Larson-Prior L.J.; Atypical resting-state functional connectivity of affective pain regions in chronic migraine. Headache  2013,53(5),737-751","journal-title":"Headache"},{"key":"ref=30","author":"Sacks O.","year":"1970","unstructured":"Sacks O.;  Migraine: The Evolution of a Common Disorder  1970","journal-title":"Migraine: The Evolution of a Common Disorder"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/0333102415620251","volume":"36","author":"Laurell K.","year":"2016","unstructured":"Laurell K.; Artto V.; Bendtsen L.; Hagen K.; H\u00e4ggstr\u00f6m J.; Linde M.; S\u00f6derstr\u00f6m L.; Tronvik E.; Wessman M.; Zwart J.A.; Kallela M.; Premonitory symptoms in migraine: A cross-sectional study in 2714 persons. Cephalalgia  2016,36(10),951-959","journal-title":"Cephalalgia"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/head.13865","volume":"60","author":"Karsan N.","year":"2020","unstructured":"Karsan N.; Bose P.R.; O\u2019Daly O.; Zelaya F.O.; Goadsby P.J.; Alterations in functional connectivity during different phases of the triggered migraine attack. Headache  2020,60(7),1244-1258","journal-title":"Headache"},{"key":"ref=33","author":"Meylakh N.","year":"2019","unstructured":"Meylakh N.;  Unique neural mechanisms of the migraine brain  2019","journal-title":"Unique neural mechanisms of the migraine brain"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.vph.2005.07.001","volume":"43","author":"Arulmozhi D.K.","year":"2005","unstructured":"Arulmozhi D.K.; Veeranjaneyulu A.; Bodhankar S.L.; Migraine: Current concepts and emerging therapies. Vascul Pharmacol  2005,43(3),176-187","journal-title":"Vascul Pharmacol"},{"key":"ref=35","author":"Davidoff R.A.","year":"2002","unstructured":"Davidoff R.A.;  Migraine: Manifestations, Pathogenesis, And Management  2002","journal-title":"Migraine: Manifestations, Pathogenesis, And Management"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1743-5013.2005.00019.x","volume":"2","author":"Knight Y.","year":"2005","unstructured":"Knight Y.; Brainstem modulation of caudal trigeminal nucleus: A model for understanding migraine biology and future drug targets. Headache Curr  2005,2(5),108-118","journal-title":"Headache Curr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.npep.2015.03.006","volume":"52","author":"Tajti J.","year":"2015","unstructured":"Tajti J.; Szok D.; Majl\u00e1th Z.; Tuka B.; Cs\u00e1ti A.; V\u00e9csei L.; Migraine and neuropeptides. Neuropeptides  2015,52,19-30","journal-title":"Neuropeptides"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"Ho T.W.","year":"2010","unstructured":"Ho T.W.; Edvinsson L.; Goadsby P.J.; CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol  2010,6(10),573-582","journal-title":"Nat Rev Neurol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11916-019-0768-y","volume":"23","author":"Urits I.","year":"2019","unstructured":"Urits I.; Jones M.R.; Gress K.; Charipova K.; Fiocchi J.; Kaye A.D.; Viswanath O.; CGRP antagonists for the treatment of chronic migraines: A comprehensive review. Curr Pain Headache Rep  2019,23(5),29","journal-title":"Curr Pain Headache Rep"},{"key":"ref=40","author":"Edvinsson L.","year":"2019","unstructured":"Edvinsson L.;  Handbook of Experimental Pharmacology  2019","journal-title":"Handbook of Experimental Pharmacology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40263-019-00630-6","volume":"33","author":"Haanes K.A.","year":"2019","unstructured":"Haanes K.A.; Edvinsson L.; Pathophysiological mechanisms in migraine and the identification of new therapeutic targets. CNS Drugs  2019,33(6),525-537","journal-title":"CNS Drugs"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/14737175.2022.2049758","volume":"22","author":"Scuteri D.","year":"2022","unstructured":"Scuteri D.; Tonin P.; Nicotera P.; Bagetta G.; Corasaniti M.T.; Real world considerations for newly approved CGRP receptor antagonists in migraine care. Expert Rev Neurother  2022,22(3),221-230","journal-title":"Expert Rev Neurother"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"Ong J.J.Y.","year":"2018","unstructured":"Ong J.J.Y.; De Felice M.; Migraine treatment: Current acute medications and their potential mechanisms of action. Neurotherapeutics  2018,15(2),274-290","journal-title":"Neurotherapeutics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1212\/CON.0000000000000192","volume":"21","author":"Becker W.J.","year":"2015","unstructured":"Becker W.J.; Acute migraine treatment. Continuum (Minneap Minn)  2015,21(4 Headache),953-972","journal-title":"Continuum (Minneap Minn)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00210-006-0108-8","volume":"374","author":"Mehrotra S.","year":"2006","unstructured":"Mehrotra S.; Gupta S.; Garrelds I.M.; Villal\u00f3n C.M.; Saxena P.R.; Bogers A.J.J.C.; MaassenVanDenBrink A.; Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery. Naunyn Schmiedebergs Arch Pharmacol  2006,374(3),163-175","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=46","first-page":"8","volume":"5","author":"Rainero I.","year":"2004","unstructured":"Rainero I.; Neurobiology of Chronic Migraine. J Headache Pain  2004,5,8-9","journal-title":"J Headache Pain"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40263-013-0061-2","volume":"27","author":"Silberstein S.D.","year":"2013","unstructured":"Silberstein S.D.; Kori S.H.; Dihydroergotamine: A review of formulation approaches for the acute treatment of migraine. CNS Drugs  2013,27(5),385-394","journal-title":"CNS Drugs"},{"key":"ref=48","first-page":"199","volume":"45","author":"Villal\u00f3n C.","year":"2002","unstructured":"Villal\u00f3n C.; An introduction to migraine: From ancient treatment to functional pharmacology and antimigraine therapy . Proc West Pharmacol Soc  2002,45,199-210","journal-title":"Proc West Pharmacol Soc"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40263-013-0126-2","volume":"28","author":"Hoffmann J.","year":"2014","unstructured":"Hoffmann J.; Goadsby P.J.; Emerging targets in migraine. CNS Drugs  2014,28(1),11-17","journal-title":"CNS Drugs"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.sjpain.2013.07.001","volume":"4","author":"Gazerani P.","year":"2013","unstructured":"Gazerani P.; Cairns B.E.; New insight in migraine pathogenesis: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan. Scand J Pain  2013,4(4),208-210","journal-title":"Scand J Pain"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0733-8619(05)70295-4","volume":"15","author":"Mathew N.T.","year":"1997","unstructured":"Mathew N.T.; Serotonin 1D (5-HT1D) agonists and other agents in acute migraine. Neurol Clin  1997,15(1),61-83","journal-title":"Neurol Clin"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/13543784.2017.1283404","volume":"26","author":"Barbanti P.","year":"2017","unstructured":"Barbanti P.; Aurilia C.; Egeo G.; Fofi L.; Palmirotta R.; Serotonin receptor targeted therapy for migraine treatment: An overview of drugs in phase I and II clinical development. Expert Opin Investig Drugs  2017,26(3),269-277","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/JPR.S132833","volume":"11","author":"Negro A.","year":"2018","unstructured":"Negro A.; Koverech A.; Martelletti P.; Serotonin receptor agonists in the acute treatment of migraine: A review on their therapeutic potential. J Pain Res  2018,11,515-526","journal-title":"J Pain Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pbr.2020.05.010","volume":"255","author":"Huang P.C.","year":"2020","unstructured":"Huang P.C.; Yang F.C.; Chang C.M.; Yang C.P.; Targeting the 5-HT and 5-HT receptors for acute migraine treatment. Prog Brain Res  2020,255,99-121","journal-title":"Prog Brain Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/nedt.2006.2.3.247","volume":"2","author":"L\u00e1inez M.J.A.","year":"2006","unstructured":"L\u00e1inez M.J.A.; Rizatriptan in the treatment of migraine. Neuropsychiatr Dis Treat  2006,2(3),247-259","journal-title":"Neuropsychiatr Dis Treat"},{"year":"2022","author":"Diener H.","key":"ref=56","unstructured":"Diener H.; F\u00f6rderreuther S.; Kropp P.; Treatment of migraine attacks und preventive treatment of migraine, S 1 guideline, 2022, DGN and DMKG. Deutsche Gesellschaft f\u00fcr Neurologie (Pub.), Guidelines for diagnosis and treatment in neurology.  Available From:    www. dgn. org\/leitlinien2022"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fneur.2014.00193","volume":"5","author":"Guidetti D.","year":"2014","unstructured":"Guidetti D.; Rota E.; Morelli N.; Immovilli P.; Migraine and Stroke: \u00e2\u20ac\u0153Vascular\u00e2\u20ac\u009d Comorbidity. Front Neurol  2014,5,193","journal-title":"Front Neurol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.pain.2013.04.019","volume":"154","author":"Goadsby P.J.","year":"2013","unstructured":"Goadsby P.J.; All that is obvious is not clear: What is the origin of throbbing pain in migraine? Pain  2013,154(7),970-971","journal-title":"Pain"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/brain\/awz134","volume":"142","author":"Goadsby P.J.","year":"2019","unstructured":"Goadsby P.J.; Wietecha L.A.; Dennehy E.B.; Kuca B.; Case M.G.; Aurora S.K.; Gaul C.; Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain  2019,142(7),1894-1904","journal-title":"Brain"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10072-019-03766-x","volume":"40","author":"Khazaei M.","year":"2019","unstructured":"Khazaei M.; Hosseini Nejad Mir N.; Yadranji Aghdam F.; Taheri M.; Ghafouri-Fard S.; Effectiveness of intravenous dexamethasone, metoclopramide, ketorolac, and chlorpromazine for pain relief and prevention of recurrence in the migraine headache: A prospective double-blind randomized clinical trial. Neurol Sci  2019,40(5),1029-1033","journal-title":"Neurol Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.annemergmed.2016.09.031","volume":"69","author":"Avcu N.","year":"2017","unstructured":"Avcu N.; Do\u011fan N.\u00d6.; Pekdemir M.; Yaka E.; Y\u0131lmaz S.; Alye\u015fil C.; Akal\u0131n L.E.; Intranasal lidocaine in acute treatment of migraine: A randomized controlled trial. Ann Emerg Med  2017,69(6),743-751","journal-title":"Ann Emerg Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuropharm.2014.04.018","volume":"84","author":"S\u00e1nchez-Porras R.","year":"2014","unstructured":"S\u00e1nchez-Porras R.; Santos E.; Sch\u00f6ll M.; Stock C.; Zheng Z.; Schiebel P.; Orakcioglu B.; Unterberg A.W.; Sakowitz O.W.; The effect of ketamine on optical and electrical characteristics of spreading depolarizations in gyrencephalic swine cortex. Neuropharmacology  2014,84,52-61","journal-title":"Neuropharmacology"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/head.12767","volume":"56","author":"Rao A.S.","year":"2016","unstructured":"Rao A.S.; Gelaye B.; Kurth T.; Dash P.D.; Nitchie H.; Peterlin B.L.; A randomized trial of ketorolac vs sumatripan vs placebo nasal spray (KSPN) for acute migraine. Headache  2016,56(2),331-340","journal-title":"Headache"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11916-004-0036-6","volume":"8","author":"Dodick D.W.","year":"2004","unstructured":"Dodick D.W.; Indomethacin-responsive headache syndromes. Curr Pain Headache Rep  2004,8(1),19-26","journal-title":"Curr Pain Headache Rep"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1111\/bph.15657","volume":"178","author":"Zobdeh F.","year":"2021","unstructured":"Zobdeh F.; ben Kraiem A.; Attwood M.M.; Chubarev V.N.; Tarasov V.V.; Schi\u00f6th H.B.; Mwinyi J.; Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments. Br J Pharmacol  2021,178(23),4588-4607","journal-title":"Br J Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1177\/0333102419855080","volume":"39","author":"Krege J.H.","year":"2019","unstructured":"Krege J.H.; Rizzoli P.B.; Liffick E.; Doty E.G.; Dowsett S.A.; Wang J.; Buchanan A.S.; Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN. Cephalalgia  2019,39(8),957-966","journal-title":"Cephalalgia"},{"year":"2020","author":"Conway C.","key":"ref=67","unstructured":"Conway C.; Croop R.; Dubowchik G.; Coric V.; Lipton R.; Enterprises AAN;   2020"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/WNO.0000000000001053","volume":"40","author":"Konstantinos S.","year":"2020","unstructured":"Konstantinos S.; Vikelis M.; Rapoport A.; Acute care and treatment of migraine. J Neuroophthalmol  2020,40(4),472-484","journal-title":"J Neuroophthalmol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.48208\/HeadacheMed.2023.27","volume":"14","author":"Silva-N\u00e9to R.P.","year":"2023","unstructured":"Silva-N\u00e9to R.P.; Jevoux C.; Krymchantowski A.; Preventive and abortive treatment of migraine with traditional drugs. The state of the art. Headache Medicine  2023,14(3),133-143","journal-title":"Headache Medicine"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.3390\/nu13124433","volume":"13","author":"Fila M.","year":"2021","unstructured":"Fila M.; Chojnacki C.; Chojnacki J.; Blasiak J.; Nutrients to improve mitochondrial function to reduce brain energy deficit and oxidative stress in migraine. Nutrients  2021,13(12),4433","journal-title":"Nutrients"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/antiox9020116","volume":"9","author":"Goschorska M.","year":"2020","unstructured":"Goschorska M.; Gutowska I.; Baranowska-Bosiacka I.; Barczak K.; Chlubek D.; The use of antioxidants in the treatment of migraine. Antioxidants  2020,9(2),116","journal-title":"Antioxidants"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1080\/10408398.2013.812059","volume":"56","author":"Baiano A.","year":"2016","unstructured":"Baiano A.; Del Nobile M.A.; Antioxidant compounds from vegetable matrices: Biosynthesis, occurrence, and extraction systems. Crit Rev Food Sci Nutr  2016,56(12),2053-2068","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1002\/anie.201107724","volume":"51","author":"Esatbeyoglu T.","year":"2012","unstructured":"Esatbeyoglu T.; Huebbe P.; Ernst I.M.A.; Chin D.; Wagner A.E.; Rimbach G.; Curcumin--from molecule to biological function. Angew Chem Int Ed  2012,51(22),5308-5332","journal-title":"Angew Chem Int Ed"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/nu10101553","volume":"10","author":"Xu X.Y.","year":"2018","unstructured":"Xu X.Y.; Meng X.; Li S.; Gan R.Y.; Li Y.; Li H.B.; Bioactivity, health benefits, and related molecular mechanisms of curcumin: Current progress, challenges, and perspectives. Nutrients  2018,10(10),1553","journal-title":"Nutrients"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/molecules21030264","volume":"21","author":"Pulido-Moran M.","year":"2016","unstructured":"Pulido-Moran M.; Moreno-Fernandez J.; Ramirez-Tortosa C.; Ramirez-Tortosa M.C.; Curcumin and Health. Molecules  2016,21(3),264","journal-title":"Molecules"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"114910","DOI":"10.1016\/j.biopha.2023.114910","volume":"164","author":"Heidari H.","year":"2023","unstructured":"Heidari H.; Shojaei M.; Askari G.; Majeed M.; Bagherniya M.; Barreto G.E.; Sahebkar A.; The impact of curcumin on migraine: A comprehensive review. Biomed Pharmacother  2023,164,114910","journal-title":"Biomed Pharmacother"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2147\/IJN.S162087","volume":"13","author":"Bulboac\u0103 A.E.","year":"2018","unstructured":"Bulboac\u0103 A.E.; Bolboac\u0103 S.D.; St\u0103nescu I.C.; Sfr\u00e2ngeu C.A.; Porfire A.; Tefas L.; Bulboac\u0103 A.C.; The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int J Nanomedicine  2018,13,3093-3103","journal-title":"Int J Nanomedicine"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ptr.7339","volume":"36","author":"Chen Y.","year":"2022","unstructured":"Chen Y.; Wang S.; Wang Y.; Role of herbal medicine for prevention and treatment of migraine. Phytother Res  2022,36(2),730-760","journal-title":"Phytother Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/B978-0-12-821974-4.00006-6","author":"Tripathi G.M.","year":"2021","unstructured":"Tripathi G.M.;  The Molecular Immunology of Neurological Diseases  2021,135-147","journal-title":"The Molecular Immunology of Neurological Diseases"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/ph203134","volume":"2","author":"Mancuso M.","year":"2009","unstructured":"Mancuso M.; Orsucci D.; Calsolaro V.; Choub A.; Siciliano G.; Coenzyme Q10 and neurological diseases. Pharmaceuticals (Basel)  2009,2(3),134-149","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=81","first-page":"17","volume":"99","author":"Ha H.","year":"2019","unstructured":"Ha H.; Gonzalez A.; Migraine headache prophylaxis. Am Fam Physician  2019,99(1),17-24","journal-title":"Am Fam Physician"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10194-015-0516-6","volume":"16","author":"Gaul C.","year":"2015","unstructured":"Gaul C.; Diener H.C.; Danesch U.; Group M.S.; Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: A randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain  2015,16(1),32","journal-title":"J Headache Pain"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13760-016-0697-z","volume":"117","author":"Shoeibi A.","year":"2017","unstructured":"Shoeibi A.; Olfati N.; Soltani Sabi M.; Salehi M.; Mali S.; Akbari Oryani M.; Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: An open-label, add-on, controlled trial. Acta Neurol Belg  2017,117(1),103-109","journal-title":"Acta Neurol Belg"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.phymed.2016.07.013","volume":"23","author":"Kim M.S.","year":"2016","unstructured":"Kim M.S.; Bang J.H.; Lee J.; Han J.S.; Baik T.G.; Jeon W.K.; Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system. Phytomedicine  2016,23(12),1356-1364","journal-title":"Phytomedicine"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.brainresbull.2011.11.002","volume":"87","author":"Zhang Z.","year":"2012","unstructured":"Zhang Z.; Peng D.; Zhu H.; Wang X.; Experimental evidence of Ginkgo biloba extract EGB as a neuroprotective agent in ischemia stroke rats. Brain Res Bull  2012,87(2-3),193-198","journal-title":"Brain Res Bull"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuint.2012.11.017","volume":"62","author":"Tulsulkar J.","year":"2013","unstructured":"Tulsulkar J.; Shah Z.A.; Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism. Neurochem Int  2013,62(2),189-197","journal-title":"Neurochem Int"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1021\/jf800488x","volume":"56","author":"Lin L.Z.","year":"2008","unstructured":"Lin L.Z.; Chen P.; Ozcan M.; Harnly J.M.; Chromatographic profiles and identification of new phenolic components of Ginkgo biloba leaves and selected products. J Agric Food Chem  2008,56(15),6671-6679","journal-title":"J Agric Food Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cbi.2009.05.010","volume":"181","author":"Shi C.","year":"2009","unstructured":"Shi C.; Zhao L.; Zhu B.; Li Q.; Yew D.T.; Yao Z.; Xu J.; Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against \u03b2-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact  2009,181(1),115-123","journal-title":"Chem Biol Interact"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/IMI.S25054","volume":"10","author":"Nash K.M.","year":"2015","unstructured":"Nash K.M.; Shah Z.A.; Current perspectives on the beneficial role of Ginkgo biloba in neurological and cerebrovascular disorders. Integr Med Insights  2015,10,1-9","journal-title":"Integr Med Insights"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10072-009-0074-2","volume":"30","author":"D\u2019Andrea G.","year":"2009","unstructured":"D\u2019Andrea G.; Bussone G.; Allais G.; Aguggia M.; D\u2019Onofrio F.; Maggio M.; Moschiano F.; Saracco M.G.; Terzi M.G.; Petretta V.; Benedetto C.; Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci  2009,30(S1)(Suppl. 1),121-124","journal-title":"Neurol Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"e74769","DOI":"10.1371\/journal.pone.0074769","volume":"8","author":"Ma L.","year":"2013","unstructured":"Ma L.; Liu X.; Zhao Y.; Chen B.; Li X.; Qi R.; Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells. PLoS One  2013,8(9),e74769","journal-title":"PLoS One"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10072-013-1413-x","volume":"34","author":"Allais G.","year":"2013","unstructured":"Allais G.; D\u2019Andrea G.; Maggio M.; Benedetto C.; The efficacy of ginkgolide B in the acute treatment of migraine aura: An open preliminary trial. Neurol Sci  2013,34(S1)(Suppl. 1),161-163","journal-title":"Neurol Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.foodchem.2005.02.024","volume":"96","author":"Wu C.","year":"2006","unstructured":"Wu C.; Chen F.; Wang X.; Kim H.J.; He G.; Haley-Zitlin V.; Huang G.; Antioxidant constituents in feverfew (Tanacetum parthenium) extract and their chromatographic quantification. Food Chem  2006,96(2),220-227","journal-title":"Food Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1468-2982.2002.00396.x","volume":"22","author":"Pfaffenrath V.","year":"2002","unstructured":"Pfaffenrath V.; Diener H.C.; Fischer M.; Friede M.; Henneicke-von Zepelin H.H.; The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia  2002,22(7),523-532","journal-title":"Cephalalgia"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"6320163","DOI":"10.1155\/2019\/6320163","volume":"2019","author":"Volta G.D.","year":"2019","unstructured":"Volta G.D.; Zavarise P.; Perego L.; Savi L.; Pezzini A.; Comparison of the effect of tanacethum parthenium, 5-hydroxy tryptophan, and magnesium (aurastop) versus magnesium alone on aura phenomenon and its evolution. Pain Res Manag  2019,2019,6320163","journal-title":"Pain Res Manag"},{"key":"ref=96","first-page":"1","author":"Paswan V.K.","year":"2021","unstructured":"Paswan V.K.; Singh C.S.; Kukreja G.; Bunkar D.S.; Bhinchhar B.K.;  Herbs and Spices-New Processing Technologies  2021,1-18","journal-title":"Herbs and Spices-New Processing Technologies"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.fitote.2015.03.012","volume":"103","author":"Laribi B.","year":"2015","unstructured":"Laribi B.; Kouki K.; M\u2019Hamdi M.; Bettaieb T.; Coriander (Coriandrum sativum L.) and its bioactive constituents. Fitoterapia  2015,103,9-26","journal-title":"Fitoterapia"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"44","DOI":"10.47176\/mjiri.34.44","volume":"34","author":"Mansouri S.","year":"2020","unstructured":"Mansouri S.; Kazemi I.; Baghestani A.R.; Zayeri F.; Ghorbanifar Z.; Evaluating the effect of Coriandrum sativum syrup on being migraine-free using mixture models. Med J Islam Repub Iran  2020,34,44","journal-title":"Med J Islam Repub Iran"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/ptr.6701","volume":"34","author":"Lopresti A.L.","year":"2020","unstructured":"Lopresti A.L.; Smith S.J.; Drummond P.D.; Herbal treatments for migraine: A systematic review of randomised-controlled studies. Phytother Res  2020,34(10),2493-2517","journal-title":"Phytother Res"},{"year":"2021","author":"Nair M.B.","key":"ref=100","unstructured":"Nair M.B.; Groot M.; Medicinal plants for Home herbal gardens, Institutional gardens and animal health.  Available From:      https:\/\/research.wur.nl\/en\/publications\/medicinal-plants-for-home-herbal-gardens-institutional-gardens-an2021"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/1874467215666220211100256","volume":"16","author":"Tiwari G.","year":"2023","unstructured":"Tiwari G.; Tiwari R.; Mishra S.; Ramachandran V.; Preventive and Therapeutic Aspects of Migraine for Patient Care: An Insight. Curr Mol Pharmacol  2023,16(2),147-160","journal-title":"Curr Mol Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40263-018-0597-2","volume":"33","author":"Rajapakse T.","year":"2019","unstructured":"Rajapakse T.; Davenport W.J.; Phytomedicines in the treatment of migraine. CNS Drugs  2019,33(5),399-415","journal-title":"CNS Drugs"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ctim.2017.08.014","volume":"34","author":"Nayebi N.","year":"2017","unstructured":"Nayebi N.; Khalili N.; Kamalinejad M.; Emtiazy M.; A systematic review of the efficacy and safety of Rosa damascena Mill. with an overview on its phytopharmacological properties. Complement Ther Med  2017,34,129-140","journal-title":"Complement Ther Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/acupmed-2012-010195","volume":"30","author":"Ferro E.C.","year":"2012","unstructured":"Ferro E.C.; Biagini A.P.; da Silva \u00cd.E.F.; Silva M.L.; Silva J.R.T.; The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: Randomised study. Acupunct Med  2012,30(4),252-257","journal-title":"Acupunct Med"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejpain.2007.06.003","volume":"12","author":"Oelkers-Ax R.","year":"2008","unstructured":"Oelkers-Ax R.; Leins A.; Parzer P.; Hillecke T.; Bolay H.V.; Fischer J.; Bender S.; Hermanns U.; Resch F.; Butterbur root extract and music therapy in the prevention of childhood migraine: An explorative study. Eur J Pain  2008,12(3),301-313","journal-title":"Eur J Pain"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/1028415X.2019.1627770","volume":"24","author":"Parohan M.","year":"2021","unstructured":"Parohan M.; Sarraf P.; Javanbakht M.H.; Foroushani A.R.; Ranji-Burachaloo S.; Djalali M.; The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial. Nutr Neurosci  2021,24(4),317-326","journal-title":"Nutr Neurosci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.mehy.2006.12.024","volume":"69","author":"Haghighi A.B.","year":"2007","unstructured":"Haghighi A.B.; Motazedian S.; Rezaii R.; Therapeutic potentials of menthol in migraine headache: Possible mechanisms of action. Med Hypotheses  2007,69(2),455","journal-title":"Med Hypotheses"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.fct.2008.11.006","volume":"47","author":"Burdock G.A.","year":"2009","unstructured":"Burdock G.A.; Carabin I.G.; Safety assessment of coriander (Coriandrum sativum L.) essential oil as a food ingredient. Food Chem Toxicol  2009,47(1),22-34","journal-title":"Food Chem Toxicol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","volume":"22","author":"Anderson G.","year":"2016","unstructured":"Anderson G.; Seo M.; Berk M.; Carvalho A.; Maes M.; Gut permeability and microbiota in Parkinson\u2019s disease: Role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways. Curr Pharm Des  2016,22(40),6142-6151","journal-title":"Curr Pharm Des"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/00365521.2023.2298370","volume":"59","author":"Meng X.","year":"2024","unstructured":"Meng X.; Li Q.; Wang D.; Li J.; Cui Y.; Sun Z.; Yin H.; Exploring the role of gut microbiota in migraine risk: A two-sample Mendelian randomization study. Scand J Gastroenterol  2024,59(4),411-418","journal-title":"Scand J Gastroenterol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ph16050686","volume":"16","author":"Ivanova A.Y.","year":"2023","unstructured":"Ivanova A.Y.; Shirokov I.V.; Toshchakov S.V.; Kozlova A.D.; Obolenskaya O.N.; Mariasina S.S.; Ivlev V.A.; Gartseev I.B.; Medvedev O.S.; Effects of coenzyme Q10 on the biomarkers (Hydrogen, Methane, SCFA and TMA) and composition of the gut microbiome in rats. Pharmaceuticals (Basel)  2023,16(5),686","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"e26030","DOI":"10.1016\/j.heliyon.2024.e26030","volume":"10","author":"Sun J.","year":"2024","unstructured":"Sun J.; Xie Q.; Sun M.; Zhang W.; Wang H.; Liu N.; Wang M.; Curcumin protects mice with myasthenia gravis by regulating the gut microbiota, short-chain fatty acids, and the Th17\/Treg balance. Heliyon  2024,10(4),e26030","journal-title":"Heliyon"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3390\/pharmaceutics15122746","volume":"15","author":"Yu T.","year":"2023","unstructured":"Yu T.; Xing Y.; Gao Q.; Wang D.; Chen H.; Wang H.; Zhang Y.; Ginkgo biloba extract drives gut flora and microbial metabolism variation in a mouse model of alzheimer\u2019s disease. Pharmaceutics  2023,15(12),2746","journal-title":"Pharmaceutics"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.2174\/1381612825666190920114611","volume":"25","author":"Anderson G.","year":"2019","unstructured":"Anderson G.; Integrating pathophysiology in migraine: Role of the gut microbiome and melatonin. Curr Pharm Des  2019,25(33),3550-3562","journal-title":"Curr Pharm Des"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/jpi.12026","volume":"54","author":"Tan D.X.","year":"2013","unstructured":"Tan D.X.; Manchester L.C.; Liu X.; Rosales-Corral S.A.; Acuna-Castroviejo D.; Reiter R.J.; Mitochondria and chloroplasts as the original sites of melatonin synthesis: A hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes. J Pineal Res  2013,54(2),127-138","journal-title":"J Pineal Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3390\/ijms24043651","volume":"24","author":"Mokkawes T.","year":"2023","unstructured":"Mokkawes T.; de Visser S.P.; Melatonin activation by cytochrome P450 isozymes: How does CYP1A2 compare to CYP1A1? Int J Mol Sci  2023,24(4),3651","journal-title":"Int J Mol Sci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1073\/pnas.0912531107","volume":"107","author":"Jang S.W.","year":"2010","unstructured":"Jang S.W.; Liu X.; Pradoldej S.; Tosini G.; Chang Q.; Iuvone P.M.; Ye K.; N -acetylserotonin activates TrkB receptor in a circadian rhythm. Proc Natl Acad Sci USA  2010,107(8),3876-3881","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1292\/jvms.11-0123","volume":"73","author":"Yoo D.Y.","year":"2011","unstructured":"Yoo D.Y.; Nam S.M.; Kim W.; Lee C.H.; Won M.H.; Hwang I.K.; Yoon Y.S.; N-acetylserotonin increases cell proliferation and differentiating neuroblasts with tertiary dendrites through upregulation of brain-derived neurotrophic factor in the mouse dentate gyrus. J Vet Med Sci  2011,73(11),1411-1416","journal-title":"J Vet Med Sci"},{"key":"ref=119","first-page":"8","volume":"6","author":"Guo J-Q.","year":"2017","unstructured":"Guo J-Q.; Deng H-H.; Bo X.; Yang X-S.; Involvement of BDNF\/TrkB and ERK\/CREB axes in nitroglycerin-induced rat migraine and effects of estrogen on these signals in the migraine. Biol Open  2017,6(1),8-16","journal-title":"Biol Open"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1474-4422(24)00003-6","volume":"23","author":"Chiang C.C.","year":"2024","unstructured":"Chiang C.C.; Porreca F.; Robertson C.E.; Dodick D.W.; Potential treatment targets for migraine: Emerging options and future prospects. Lancet Neurol  2024,23(3),313-324","journal-title":"Lancet Neurol"}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249308649240730093046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233869\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249308649240730093046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:40:17Z","timestamp":1762497617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233869\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715249308649240730093046","relation":{},"ISSN":["1871-5249"],"issn-type":[{"type":"print","value":"1871-5249"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}